HomeCompareIBXNF vs YUM

IBXNF vs YUM: Dividend Comparison 2026

IBXNF yields 200.00% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBXNF wins by $119.26M in total portfolio value
10 years
IBXNF
IBXNF
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full IBXNF calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — IBXNF vs YUM

📍 IBXNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBXNFYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBXNF + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBXNF pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXNF
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, IBXNF beats the other by $51,115,718.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXNF + YUM for your $10,000?

IBXNF: 50%YUM: 50%
100% YUM50/50100% IBXNF
Portfolio after 10yr
$59.74M
Annual income
$30,108,026.80/yr
Blended yield
50.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

IBXNF
No analyst data
Altman Z
5.4
Piotroski
6/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXNF buys
0
YUM buys
0
No recent congressional trades found for IBXNF or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBXNFYUM
Forward yield200.00%1.85%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$119.36M$107.0K
Annual income after 10y$60,176,096.29$39,957.33
Total dividends collected$112.49M$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: IBXNF vs YUM ($10,000, DRIP)

YearIBXNF PortfolioIBXNF Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$30,700$20,000.00$10,980$280.44+$19.7KIBXNF
2$90,232$57,383.18$12,185$435.72+$78.0KIBXNF
3$254,173$157,624.56$13,722$684.14+$240.5KIBXNF
4$686,927$414,961.74$15,773$1,090.14+$671.2KIBXNF
5$1,783,118$1,048,106.39$18,650$1,773.02+$1.76MIBXNF
6$4,450,613$2,542,677.12$22,921$2,966.37+$4.43MIBXNF
7$10,693,420$5,931,263.38$29,685$5,158.69+$10.66MIBXNF
8$24,760,608$13,318,648.86$41,216$9,453.02+$24.72MIBXNF
9$55,315,649$28,821,798.66$62,672$18,571.31+$55.25MIBXNF
10$119,363,841$60,176,096.29$107,016$39,957.33+$119.26MIBXNF

IBXNF vs YUM: Complete Analysis 2026

IBXNFStock

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Full IBXNF Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this IBXNF vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXNF vs SCHDIBXNF vs JEPIIBXNF vs OIBXNF vs KOIBXNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.